Stock Market Today: SPY, QQQ Reverse Gains as Iran Calls Off Peace Talks; Trump Extends Ceasefire Deadline

The market is pricing this as a geopolitical de-escalation headline, but the more important effect is cross-asset duration. If the ceasefire framework holds even imperfectly, it reduces the probability of a near-term energy shock, which mechanically supports multiples for long-duration growth and lowers the odds of a broader risk-off de-rating. That helps explain why semis and mega-cap tech can absorb index volatility better than cyclicals tied to input costs or defense spending.

For AAPL, the CEO transition matters less as a governance event than as a signaling event: investors usually pay up for continuity when a platform company is already under product-cycle scrutiny, but this handoff introduces a discount until the market sees whether capital allocation, AI roadmap, and gross margin discipline remain unchanged. The stock can underperform even without a fundamental break if the transition forces a multiple reset by 1-2 turns over the next few quarters. That creates a relative-short opportunity versus other mega-cap platforms with less key-man uncertainty.

The upside revision in broad index targets is likely lagging rather than leading. If earnings season confirms that AI capex is still translating into order growth, the beneficiaries are not just the chip designers but also the compute-supply chain and power/thermal infrastructure names that rarely get bid on the first move. AMD’s reaction suggests the market is still underpricing demand elasticity in accelerated compute, but the bigger second-order trade is that capacity tightness can keep pricing power intact longer than consensus expects.

UNH’s move looks more like a quality re-rating than a one-day beat: healthcare is offering rare earnings visibility at a moment when macro-sensitive sectors are hostage to geopolitics. The risk is that investors crowd into defensives too early and miss a reversal if the peace narrative stabilizes and rates drift higher again. Near term, the cleanest expression is to own profitable healthcare balance-sheet strength while funding it with higher-beta consumer/tech exposure that is most sensitive to headline-driven volatility.